Gland Pharma

  • Specialty generic injectables company with leadership position in Low Molecular Weight Heparin
  • Pioneered Heparin technology in India
  • Sales in India, US and 55 other countries
  • USFDA approved manufacturing facilities for a diversified portfolio of products
  • Strong formulation development capabilities, with an R&D team of ~100 scientists
  • The Fund has exited this investment
Scroll to top